These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10856099)

  • 1. Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer.
    Geels P; Eisenhauer E; Bezjak A; Zee B; Day A
    J Clin Oncol; 2000 Jun; 18(12):2395-405. PubMed ID: 10856099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21.
    Bezjak A; Tu D; Seymour L; Clark G; Trajkovic A; Zukin M; Ayoub J; Lago S; de Albuquerque Ribeiro R; Gerogianni A; Cyjon A; Noble J; Laberge F; Chan RT; Fenton D; von Pawel J; Reck M; Shepherd FA;
    J Clin Oncol; 2006 Aug; 24(24):3831-7. PubMed ID: 16921034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer.
    Langendijk JA; Aaronson NK; de Jong JM; ten Velde GP; Muller MJ; Lamers RJ; Slotman BJ; Wouters EF
    J Clin Oncol; 2001 Apr; 19(8):2123-33. PubMed ID: 11304764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvements in health-related quality of life by comprehensive cancer pain therapy: a pilot study with breast cancer outpatients under palliative chemotherapy.
    Puetzler J; Feldmann RE; Brascher AK; Gerhardt A; Benrath J
    Oncol Res Treat; 2014; 37(9):456-62. PubMed ID: 25231685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom and quality of life benefit of afatinib in advanced non-small-cell lung cancer patients previously treated with erlotinib or gefitinib: results of a randomized phase IIb/III trial (LUX-Lung 1).
    Hirsh V; Cadranel J; Cong XJ; Fairclough D; Finnern HW; Lorence RM; Miller VA; Palmer M; Yang JC
    J Thorac Oncol; 2013 Feb; 8(2):229-37. PubMed ID: 23328549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment?
    Macquart-Moulin G; Viens P; Palangié T; Bouscary ML; Delozier T; Roché H; Janvier M; Fabbro M; Moatti JP
    J Clin Oncol; 2000 Feb; 18(4):754-64. PubMed ID: 10673516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating patient reported measures as predictive parameters into decisionmaking about palliative chemotherapy: a pilot study.
    Creutzfeldt A; Suling A; Oechsle K; Mehnert A; Atanackovic D; Kripp M; Arnold D; Stein A; Quidde J
    BMC Palliat Care; 2016 Mar; 15():25. PubMed ID: 26928745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endobronchial brachytherapy for symptom palliation in non-small cell lung cancer--analysis of symptom response, endoscopic improvement and quality of life.
    Mallick I; Sharma SC; Behera D
    Lung Cancer; 2007 Mar; 55(3):313-8. PubMed ID: 17157949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life and pain in advanced stage prostate cancer: results of a Southwest Oncology Group randomized trial comparing docetaxel and estramustine to mitoxantrone and prednisone.
    ; Berry DL; Moinpour CM; Jiang CS; Ankerst DP; Petrylak DP; Vinson LV; Lara PN; Jones S; Taplin ME; Burch PA; Hussain MH; Crawford ED
    J Clin Oncol; 2006 Jun; 24(18):2828-35. PubMed ID: 16782921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The palliative benefit of irinotecan in 5-fluorouracil-refractory colorectal cancer: its prospective evaluation by a Multicenter Canadian Trial.
    Michael M; Hedley D; Oza A; Feld R; Pintilie M; Goel R; Maroun J; Jolivet J; Fields A; Lee IM; Moore MJ
    Clin Colorectal Cancer; 2002 Aug; 2(2):93-101. PubMed ID: 12453323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptom clusters during palliative chemotherapy and their influence on functioning and quality of life.
    Rha SY; Lee J
    Support Care Cancer; 2017 May; 25(5):1519-1527. PubMed ID: 28032218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acupuncture to Treat the Symptoms of Patients in a Palliative Care Setting.
    Romeo MJ; Parton B; Russo RA; Hays LS; Conboy L
    Explore (NY); 2015; 11(5):357-62. PubMed ID: 26254221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of lapatinib monotherapy on QOL and pain symptoms in patients with HER2+ relapsed or refractory inflammatory breast cancer.
    Kaufman B; Wu Y; Amonkar MM; Sherrill B; Bachelot T; Salazar V; Viens P; Johnston S
    Curr Med Res Opin; 2010 May; 26(5):1065-73. PubMed ID: 20214527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the relationship between toxicity and quality of life in an ovarian cancer chemotherapy clinical trial.
    Butler L; Bacon M; Carey M; Zee B; Tu D; Bezjak A
    J Clin Oncol; 2004 Jun; 22(12):2461-8. PubMed ID: 15197209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life in metastatic breast cancer patients under chemotherapy or supportive care: a single-institution comparative study.
    Karamouzis MV; Ioannidis G; Rigatos G
    Eur J Cancer Care (Engl); 2007 Sep; 16(5):433-8. PubMed ID: 17760930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric Cancer.
    Kim JW; Kim JG; Kang BW; Chung IJ; Hong YS; Kim TY; Song HS; Lee KH; Zang DY; Ko YH; Song EK; Baek JH; Koo DH; Oh SY; Cho H; Lee KW
    Cancer Res Treat; 2019 Jan; 51(1):223-239. PubMed ID: 30584995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study.
    Langendijk JA; ten Velde GP; Aaronson NK; de Jong JM; Muller MJ; Wouters EF
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):149-55. PubMed ID: 10758317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer.
    King MT; Stockler MR; Butow P; O'Connell R; Voysey M; Oza AM; Gillies K; Donovan HS; Mercieca-Bebber R; Martyn J; Sjoquist K; Friedlander ML
    Int J Gynecol Cancer; 2014 Jun; 24(5):865-73. PubMed ID: 24844220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.